Alenka B. Blagaic

Zagreb, 10000, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Oxidative Stress and Down Syndrome: A Systematic Review.

Oxidative Stress and Down Syndrome: A Systematic Review.

Journal: Antioxidants (Basel, Switzerland)

Published: March 27, 2025

Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in Rats.

Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in Rats.

Journal: Current neuropharmacology

Published: March 21, 2025

Stable Gastric Pentadecapeptide BPC 157 Therapy: Effect on Reperfusion Following Maintained Intra-Abdominal Hypertension (Grade III and IV) in Rats.

Stable Gastric Pentadecapeptide BPC 157 Therapy: Effect on Reperfusion Following Maintained Intra-Abdominal Hypertension (Grade III and IV) in Rats.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 22, 2023

Pentadecapeptide BPC 157 as Therapy for Inferior Caval Vein Embolization: Recovery of Sodium Laurate-Post-Embolization Syndrome in Rats.

Pentadecapeptide BPC 157 as Therapy for Inferior Caval Vein Embolization: Recovery of Sodium Laurate-Post-Embolization Syndrome in Rats.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 25, 2023

Pharmacokinetic Analysis of Ethanol in a Human Study: New Modification of Mathematic Model.

Pharmacokinetic Analysis of Ethanol in a Human Study: New Modification of Mathematic Model.

Journal: Toxics

Published: August 05, 2023

Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle.

Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle.

Journal: Biomedicines

Published: October 19, 2022

Fourier Transform Infrared Spectroscopy Reveals Molecular Changes in Blood Vessels of Rats Treated with Pentadecapeptide BPC 157.

Fourier Transform Infrared Spectroscopy Reveals Molecular Changes in Blood Vessels of Rats Treated with Pentadecapeptide BPC 157.

Journal: Biomedicines

Published: October 10, 2022

Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis Presentation.

Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis Presentation.

Journal: Biomedicines

Published: September 11, 2022

Stable Gastric Pentadecapeptide BPC 157: Prompt Particular Activation of Collateral Pathways.

Stable Gastric Pentadecapeptide BPC 157: Prompt Particular Activation of Collateral Pathways.

Journal: Current medicinal chemistry

Published: March 01, 2022

Corrigendum: Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats.

Corrigendum: Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats.

Journal: Frontiers in pharmacology

Published: December 29, 2021

Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome.

Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome.

Journal: World journal of gastroenterology

Published: March 21, 2021

Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.

Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.

Journal: Frontiers in pharmacology

Published: November 09, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026